A new hope for GeNeuro

It’s only about two weeks ago when GeNeuro’s hopes for a quick win with its HERV-W human endogenous retrovirus program…

Rise of the Natural Killer Cell

In immunotherapy, a lot of research and clinical development programs have so far focused on T-cell mediated tumor killing. PD1…

Positive ARIEL-3 readout

The PARP space continues to generate positive data. Clovis Oncology just released positive rucaparib topline data in the maintenance treatment…